Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
SSM Popul Health ; 19: 101207, 2022 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-35992966

RESUMO

Vaccine hesitancy is a well-known phenomenon whereby individuals in a population reject or delay being vaccinated despite having access to vaccine services. This phenomenon is especially problematic in the current context of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) pandemic because vaccine hesitancy can decrease vaccination rates. In Mexico, vaccine hesitancy has been less thoroughly studied than in other countries such as the United States despite its importance and the potential impact of overlooking the problem. Understanding and effectively tackling this problem requires a more in-depth analysis of the defining characteristics of vaccination hesitancy. For this purpose, the World Health Organization's (WHO) Vaccine Hesitancy Determinants Matrix (VHDM in this study) is highly useful. In the present study, a digital survey was conducted using Google Forms to assess the level of vaccine hesitancy in the Mexican population and the vaccine determinants of the VHDM model associated with the respondents' different levels of vaccine hesitancy. The sample consisted of 1,195 people divided into four levels of vaccine hesitancy based on their answers. Tests for association were performed, identifying an association between some determinants of the VHDM model and the levels of vaccine hesitancy. Based on the analysis of the survey results, areas of opportunity for addressing COVID-19 vaccine hesitancy in Mexico were found and discussed; these included the importance of studying vaccine hesitancy as a complex and changing gradient, the high connectivity of people with high level of vaccine hesitancy to networks of people with vaccine hesitancy, the relatively high trust in physicians at all levels of vaccine hesitancy, the low trust in government authorities at high and moderate levels of vaccine hesitancy, and the strong association of the fear of suffering side effects and knowing people who have suffered them with the level of vaccine hesitancy.

2.
PLoS One ; 13(5): e0197116, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29771959

RESUMO

Hybridization events are frequently demonstrated in natural butterfly populations. One interesting butterfly complex species is the Enantia jethys complex that has been studied for over a century; many debates exist regarding the species composition of this complex. Currently, three species that live sympatrically in the Gulf slope of Mexico (Enantia jethys, E. mazai, and E. albania) are recognized in this complex (based on morphological and molecular studies). Where these species live in sympatry, some cases of interspecific mating have been observed, suggesting hybridization events. Considering this, we employed a multilocus approach (analyses of mitochondrial and nuclear sequences: COI, RpS5, and Wg; and nuclear dominant markers: inter-simple sequence repeat (ISSRs) to study hybridization in sympatric populations from Veracruz, Mexico. Genetic diversity parameters were determined for all molecular markers, and species identification was assessed by different methods such as analyses of molecular variance (AMOVA), clustering, principal coordinate analysis (PCoA), gene flow, and PhiPT parameters. ISSR molecular markers were used for a more profound study of hybridization process. Although species of the Enantia jethys complex have a low dispersal capacity, we observed high genetic diversity, probably reflecting a high density of individuals locally. ISSR markers provided evidence of a contemporary hybridization process, detecting a high number of hybrids (from 17% to 53%) with significant differences in genetic diversity. Furthermore, a directional pattern of hybridization was observed from E. albania to other species. Phylogenetic study through DNA sequencing confirmed the existence of three clades corresponding to the three species previously recognized by morphological and molecular studies. This study underlines the importance of assessing hybridization in evolutionary studies, by tracing the lineage separation process that leads to the origin of new species. Our research demonstrates that hybridization processes have a high occurrence in natural populations.


Assuntos
DNA Mitocondrial/genética , Evolução Molecular , Variação Genética , Lepidópteros/genética , Animais , México
3.
Chromosoma ; 126(6): 697-712, 2017 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-28688038

RESUMO

Telomeres are important contributors to genome stability, as they prevent linear chromosome end degradation and contribute to the avoidance of telomeric fusions. An important component of the telomeres is the heterochromatin protein 1a (HP1a). Mutations in Su(var)205, the gene encoding HP1a in Drosophila, result in telomeric fusions, retrotransposon regulation loss and larger telomeres, leading to chromosome instability. Previously, it was found that several proteins physically interact with HP1a, including dXNP and dAdd1 (orthologues to the mammalian ATRX gene). In this study, we found that mutations in the genes encoding the dXNP and dAdd1 proteins affect chromosome stability, causing chromosomal aberrations, including telomeric defects, similar to those observed in Su(var)205 mutants. In somatic cells, we observed that dXNP and dAdd1 participate in the silencing of the telomeric HTT array of retrotransposons, preventing anomalous retrotransposon transcription and integration. Furthermore, the lack of dAdd1 results in the loss of HP1a from the telomeric regions without affecting other chromosomal HP1a binding sites; mutations in dxnp also affected HP1a localization but not at all telomeres, suggesting a specialized role for dAdd1 and dXNP proteins in locating HP1a at the tips of the chromosomes. These results place dAdd1 as an essential regulator of HP1a localization and function in the telomere heterochromatic domain.


Assuntos
Proteínas Cromossômicas não Histona/metabolismo , DNA Helicases/metabolismo , Proteínas de Drosophila/metabolismo , Drosophila/genética , Drosophila/metabolismo , Instabilidade Genômica , Telômero/genética , Telômero/metabolismo , Animais , Animais Geneticamente Modificados , Homólogo 5 da Proteína Cromobox , Aberrações Cromossômicas , Feminino , Inativação Gênica , Heterocromatina/metabolismo , Perda de Heterozigosidade , Masculino , Mutação , Transporte Proteico , Retroelementos
4.
Toxicol Ind Health ; 33(5): 443-453, 2017 May.
Artigo em Inglês | MEDLINE | ID: mdl-27777339

RESUMO

The aim of this study was to evaluate the genotoxicity of the herbicide diuron in the wing-spot test and a novel wing imaginal disk comet assay in Drosophila melanogaster. The wing-spot test was performed with standard (ST) and high-bioactivation (HB) crosses after providing chronic 48 h treatment to third instar larvae. A positive dose-response effect was observed in both crosses, but statistically reduced spot frequencies were registered for the HB cross compared with the ST. This latter finding suggests that metabolism differences play an important role in the genotoxic effect of diuron. To verify diuron's ability to produce DNA damage, a wing imaginal disk comet assay was performed after providing 24 h diuron treatment to ST and HB third instar larvae. DNA damage induced by the herbicide had a significantly positive dose-response effect even at very low concentrations in both strains. However, as noted for the wing-spot test, a significant difference between strains was not observed that could be related to the duration of exposure between both assays. A positive correlation between the comet assay and the wing-spot test was found with regard to diuron genotoxicity.


Assuntos
Dano ao DNA/efeitos dos fármacos , Diurona/toxicidade , Drosophila melanogaster , Herbicidas/toxicidade , Animais , Ensaio Cometa , Drosophila melanogaster/efeitos dos fármacos , Drosophila melanogaster/genética , Feminino , Larva/efeitos dos fármacos , Larva/crescimento & desenvolvimento , Masculino , Testes de Mutagenicidade , Asas de Animais/efeitos dos fármacos , Asas de Animais/crescimento & desenvolvimento , Asas de Animais/patologia
5.
J Med Food ; 14(9): 1018-22, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-21554118

RESUMO

Four medicinal plants--Tecoma stans, Ligusticum porteri, Monarda austromontana, and Poliomintha longiflora, which are distributed in tropical and subtropical countries of the American continent--are widely used in folk medicine to treat diseases such as diarrhea and dysentery. In addition, T. stans and P. longiflora are extensively used as hypoglycemic agents, and M. austromontana and P. longiflora are used as condiments. The plants were collected, identified, dried, and pulverized. Solvent extraction was prepared by maceration of the plant samples, and the phytochemical composition of the extracts was determined by using standard analysis procedures. Phytochemical analysis showed the presence of triterpenoids/steroids, flavonoids, and phenols/tannins and, in L. porteri, traces of alkaloids. After the elimination of solvents in vacuo, the extracts were administrated to Drosophila larvae to test their toxicity and genotoxicity. Third instar larvae were chronically fed with the phytoextracts. The extract from L. porteri was toxic, whereas those from T. stans, P. longiflora, and M. austromontana were not. Genotoxic activities of the 4 plants were investigated by using the wing-spot assay of D. melanogaster. Mitomycin C was used as a positive control. No statistically significant increase was observed between treated sample series and a concurrent negative (water) or solvent control sample series.


Assuntos
Medicina Tradicional/efeitos adversos , Mutagênicos/toxicidade , Extratos Vegetais/toxicidade , Plantas Medicinais/química , Animais , Bignoniaceae/química , América Central , Drosophila/efeitos dos fármacos , Drosophila/genética , Feminino , Lamiaceae/química , Larva/efeitos dos fármacos , Larva/genética , Ligusticum/química , Masculino , Testes de Mutagenicidade , Mutagênicos/análise , Extratos Vegetais/química , Folhas de Planta/química , Raízes de Plantas/química , América do Sul , Testes de Toxicidade Crônica
6.
Pharm Biol ; 49(6): 640-7, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21391834

RESUMO

CONTEXT AND OBJECTIVE: We used the wing somatic assay in Drosophila melanogaster to test the hypothesis that two phytoextracts from Cecropia obtusifolia Bertol (Cecropiaceae) and Equisetum myriochaetum Schlecht. et Cham (Equisetaceae), which are used in folk medicine to treat type 2 diabetes mellitus, could detoxify the mutagen hydrogen peroxide. MATERIALS AND METHODS: Third instar larvae from standard (ST) and high-bioactivation (HB) crosses were chronically exposed to different concentrations of the phytoextracts. Hydrogen peroxide was used to induce oxidative stress and was chronically tested in both crosses. Catalase activity was measured in larvae of both strains 48 h after treatment with hydrogen peroxide. A pretreatment protocol was devised to test the antimutagenic potency of the medicinal extracts. RESULTS: The present study showed that neither of the phytoextracts were genotoxic in Drosophila. Interestingly, the antioxidant enzyme activity levels were different between the larvae. Hydrogen peroxide resulted in a significant genotoxic effect in the ST cross, whereas a detoxification of hydrogen peroxide was found in the HB cross. Thus, catalase was stimulated in the HB cross, which was indicative of a cellular defense mechanism mounted against a xenobiotic hazard. We found that the percentage of inhibition of spots produced by E. myriochaetum was much higher than that induced by Cecropia obtusifolia. DISCUSSION AND CONCLUSIONS: These results are in agreement with the uses of these phytoextracts in traditional medicine. Indeed, the lack of genotoxicity and the antimutagenic activity observed for both phytoextracts validates their use as a therapeutic modality to treat diabetic patients. Moreover, these extracts are suitable for consumption as teas and/or phytomedicines.


Assuntos
Antimutagênicos/farmacologia , Cecropia/química , Drosophila melanogaster , Equisetum/química , Extratos Vegetais/farmacologia , Animais , Catalase/metabolismo , Cruzamentos Genéticos , Dano ao DNA/efeitos dos fármacos , Relação Dose-Resposta a Droga , Feminino , Peróxido de Hidrogênio/farmacologia , Técnicas In Vitro , Larva/efeitos dos fármacos , Larva/enzimologia , Masculino , Medicina Tradicional , México , Estresse Oxidativo/efeitos dos fármacos , Extratos Vegetais/química
7.
J Toxicol Environ Health A ; 70(20): 1713-6, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17885927

RESUMO

Emetine is one of the two active ingredients of syrup of ipecac which is used medicinally as antiparasitic and emetic, however little is known about its genotoxic activity. The goal of this study was to determine whether and how emetine and/or its metabolites might produce mitotic recombination using the in vivo Drosophila w/w+ eye somatic assay. A standard strain (which expresses basal levels of cytochrome P450 enzymes) and an insecticide-resistant strain (which constitutively over-expresses P450 genes) were employed. The results showed that emetine and/or its metabolites are active in the assay and that the genotoxic potential is significantly influenced in the presence of higher than normal concentrations of P450.


Assuntos
Amebicidas/toxicidade , Sistema Enzimático do Citocromo P-450/efeitos dos fármacos , Emetina/toxicidade , Células Híbridas/efeitos dos fármacos , Mutagênicos/toxicidade , Amebicidas/metabolismo , Animais , Sistema Enzimático do Citocromo P-450/genética , Relação Dose-Resposta a Droga , Drosophila melanogaster , Emetina/metabolismo , Testes de Mutagenicidade , Mutagênicos/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA